Keynote - Advancing public health by unlocking Wallonia’s potential in prophylactic vaccine trials

This presentation will highlight the findings of a feasibility study exploring how Belgium, long recognised for its excellence in clinical trials, can reclaim its leadership in vaccine research in response to shifting global dynamics and new EU regulations. The study outlines a two-phase plan to create a national network for prophylactic vaccine trials, beginning with capacity building in Wallonia. This coordinated effort aims to drive job growth, enhance public health preparedness and restore Belgium’s global standing in vaccine research.